The ins and outs of intracellular peptides and antigen presentation by MHC class I molecules
- PMID: 16573239
- DOI: 10.1007/3-540-28007-3_6
The ins and outs of intracellular peptides and antigen presentation by MHC class I molecules
Abstract
MHC class I molecules present small intracellular generated fragments to the outside surveying immune system. This is the result of a series of biochemical processes involving biosynthesis, degradation, translocation, intracellular transport, diffusion, and many more. Critical intermediates and end products of this cascade of events are peptides. The peptides are generated by the proteasome, degraded by peptidases unless transported into the ER where another peptidase and MHC class I molecules are waiting. Unless peptides bind to MHC class I molecules, they are released from the ER and enter the cytoplasm by a system resembling the ERAD pathway in many aspects. The cycle of peptides over the ER membrane with the proteasome at the input site and peptidases or MHC class I molecules on the output site are central in the MHC class I antigen presentation pathway and this review.
Similar articles
-
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.Immunity. 2003 Jan;18(1):97-108. doi: 10.1016/s1074-7613(02)00511-3. Immunity. 2003. PMID: 12530979
-
Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER.Immunity. 1999 Aug;11(2):241-51. doi: 10.1016/s1074-7613(00)80099-0. Immunity. 1999. PMID: 10485659
-
Viral immune evasion: Lessons in MHC class I antigen presentation.Semin Immunol. 2015 Mar;27(2):125-37. doi: 10.1016/j.smim.2015.03.010. Epub 2015 Apr 15. Semin Immunol. 2015. PMID: 25887630 Review.
-
Prediction of intracellular targets of a small compound by analyzing peptides presented on MHC class I.Biochem Biophys Res Commun. 2019 Jan 8;508(2):480-486. doi: 10.1016/j.bbrc.2018.11.089. Epub 2018 Nov 29. Biochem Biophys Res Commun. 2019. PMID: 30503339
-
The peptide-loading complex--antigen translocation and MHC class I loading.Biol Chem. 2009 Aug;390(8):783-94. doi: 10.1515/BC.2009.069. Biol Chem. 2009. PMID: 19426129 Review.
Cited by
-
Reconstruction of a pathway of antigen processing and class II MHC peptide capture.EMBO J. 2007 Apr 18;26(8):2137-47. doi: 10.1038/sj.emboj.7601660. Epub 2007 Mar 29. EMBO J. 2007. PMID: 17396153 Free PMC article.
-
HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation.mBio. 2020 Oct 27;11(5):e02221-19. doi: 10.1128/mBio.02221-19. mBio. 2020. PMID: 33109760 Free PMC article.
-
Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.Cancer Res. 2009 Dec 1;69(23):9012-9. doi: 10.1158/0008-5472.CAN-09-2019. Epub 2009 Nov 10. Cancer Res. 2009. PMID: 19903852 Free PMC article.
-
Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.Immunol Res. 2011 Dec;51(2-3):237-48. doi: 10.1007/s12026-011-8257-3. Immunol Res. 2011. PMID: 22101673 Review.
-
Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap.Anal Chem. 2010 Nov 1;82(21):9090-9. doi: 10.1021/ac102387t. Epub 2010 Oct 8. Anal Chem. 2010. PMID: 20932029 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials